The use of continuous intrathecal infusion of octreotide in patients with chronic pain of noncancer origin: An evaluation of efficacy in a prospective double-blind fashion

Neuromodulation

Volumn 9, Issue 4, 2006, Pages 284-289

  Deer, Timothy R ^a   Penn, Richard ^a   Kim, Christopher K ^a   Bowman, Richard G ^a   Norris, Matthew ^a   Stewart, C Douglas ^a   Garten, Tina G ^a   Tolentino Jr , Wilfrido ^a   Khan, Yusuf ^a  

^a Center for Pain Relief   (United States)

Author keywords

Chronic pain; Intrathecal; Octreotide

Indexed keywords

OCTREOTIDE; PLACEBO; SODIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; PAIN ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VISUAL ANALOG SCALE;

EID: 33748753243     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2006.00070.x     Document Type: Article

References (6)

1. Gracies JM, Nance P, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity, part II: general and regional treatments. Muscle Nerve Suppl 1997;6:S92-S120.
2. Penn RD. Two decades of improved pain control. J Support Oncol 2005;3:411-412.
3. Hassenbusch SJ, Portenoy RK. Current practices in intraspinal therapy-a survey of clinical trends and decision making. J Pain Symptom Manage 2000;20:S4-S11.
4. Hassenbusch SJ, Portenoy RK, Cousins M et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug deliveryreport of an expert panel. J Pain Symptom Manage 2004;27:540-563.
5. Penn RD, Paice JA, Kroin JS. Octreotide: a potent new nonopiate analgesic for intrathecal infusion. Pain 1992;49:13-19.
6. Deer TR, Kim CK, Bowman RG et al. The use of continuous intrathecal infusion of octreotide in patients with chronic pain of noncancer origin: an evaluation side-effects toxicity a prospective double blind fashion. Neuromodulation 2005;8:171-175.